Scientists have found evidence that tamoxifen, the drug widely used to treat breast cancer, may lose its effectiveness over time and begin to behave like the hormone it is supposed to block. Tamoxifen works by blocking the action of estrogen and keeping it from attaching to a receptor on the surface of the cell.
Researchers at Duke University Medical Center have found that after a period of two to five years, the "anti-estrogen effect of tamoxifen fades, often allowing estorgen-sensitive cancers to start growing again." The primary author of the study, John D. Norris, explained that "over time, the drug causes the estrogen receptor on cells to change and form a pocket-like structure that allows other proteins to bind there. The action of these proteins somehow changed the cellís reaction to tamoxifen. The drug converts from an anti-estrogen effect to a pro-estrogen effect."
However, the scientists have discovered that the action can be reversed with the use of peptides. They also believe that this will allow them the opportunity to find a new drug anti-estrogen drug that does not have the same effects as tamoxifen
Media Resources: Nando Times and Reuters - July 29, 1999
10/7/2015 Study Finds US Gender Wage Gap Persists - Data compiled by the US Census Bureau this week once again demonstrates a gender wage gap, showing that American women who work full-time, year-round jobs on average earn 79 cents for every dollar paid to men. . . .
10/6/2015 Australia Deports Anti-Abortion Extremist Troy Newman - Anti-abortion extremist Troy Newman has been deported from Australia after an appeal to remain in the country failed to convince the High Court.
Newman was scheduled to speak at a 10-day Right To Life Australia event, but was detained in Denver, Colorado after Immigration Minister Peter Dutton cancelled his visa citing as grounds for revocation Newman's prior history of promoting violence against abortion providers and their patients. . . .
10/6/2015 Sheryl Sandberg Releases Women In the Workplace Study - Sheryl Sandberg, COO of Facebook and the founder of Lean In has launched Women In The Workplace, a study that looks at the state of women in corporate America.
The study, which was released last week, is an ongoing partnership between Lean In and McKinsey & Company. . . .